Leading the Charge: How the Private Sector is Advancing Alzheimer’s Diagnosis with Blood Biomarkers
19 Mar 2025
Dementia Matters Theatre
While the Biomarker Challenge aims to bring blood tests to the NHS in five years, the most advanced test - granted FDA Breakthrough Device Designation - is already available privately in the UK. Learn how this affordable, non-invasive test drives early detection and new treatment monitoring.
){kind=logo}
)
)
)
)
){kind=logo}
){kind=logo}
)